Sep 17, 2019
University of California adds new CRISPR-Cas9 patent to growing U.S. portfolio
Sep 10, 2019
Gene Editing Market Value is Expected to Reach $6.05 Billion by 2022 Report by The Business Research Company
Sep 03, 2019
University of California granted new U.S. CRISPR-Cas9 patent related to single-guide RNA
Aug 20, 2019
University of California awarded new U.S. CRISPR-Cas9 patent
Jul 23, 2019
University of California granted two new U.S. CRISPR-Cas9 patents
Jul 22, 2019
XpressBio Launches Cutting-Edge Cas9 ELISA Assay - An Essential Tool for Monitoring Cas9 Protein Levels in Cell Lines
Jul 18, 2019
Gene Editing Tools Gain an Uptick in Sales With Emphasis on Rare Genetic Disorder Management - Future Market Insights
Jul 16, 2019
University of California granted U.S. CRISPR-Cas9 patent related to production of genetically modified cells
Jun 21, 2019
Sangamo Announces Upcoming Presentation Of Investigational SB-525 Hemophilia A Gene Therapy Data At ISTH 2019
Jun 04, 2019
Parent Project Muscular Dystrophy Awards $175,000 Grant to UCLA to Explore Optimization of CRISPR Technology in Duchenne Muscular Dystrophy
Jun 04, 2019
University of California awarded additional U.S. patent for regulating gene editing and expression
May 24, 2019
Global Antifreeze Proteins Market 2019-2023 | 30% CAGR Projection over the Next Five Years | Technavio
May 23, 2019
First Successful CRISPR/Cas9 Gene Editing on International Space Station
May 16, 2019
Transomic CRISPR library to be implemented at the Victorian Centre for Functional Genomics
May 15, 2019
Sangamo Therapeutics Announces Presentations At Upcoming Scientific, Medical And Investor Conferences
May 10, 2019
Sangamo Therapeutics Announces Participation In The Bank Of America Merrill Lynch 2019 Health Care Conference
May 01, 2019
Sangamo Therapeutics Announces First Quarter 2019 Conference Call And Webcast
Apr 23, 2019
Cell Microsystems Receives New NIH Grants for Automating CRISPR Workflows
Apr 23, 2019
University of California Granted New CRISPR-Cas9 U.S. Patent, Further Expanding Patent Portfolio for Genome Editing
Apr 02, 2019
Sangamo Announces Agreement Securing Access To Large-Scale, Commercial-Grade Manufacturing Capacity At Brammer Bio